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Abstract
Three drugs, Ibuprofen, Aspirin and Erythromycin, are encapsulated in spherical Pluronic F127
micelles. The shapes and the size distributions of the micelles in dilute, aqueous solutions, with
and without drugs, are ascertained using cryo- Scanning Electron Microscopy and Dynamic Light
Scattering (DLS) experiments, respectively. Uptake of drugs above a threshold concentration is
seen to reduce the critical micellization temperature of the solution. The mean hydrodynamic
radii and polydispersities of the micelles are found to increase with decrease in temperature and
in the presence of drug molecules. The hydration of the micellar core at lower temperatures is
verified using fluorescence measurements. Increasing solution pH leads to the ionization of the
drugs incorporated in the micellar cores. This causes rupture of the micelles and release of the
drugs into the solution at the highest solution pH value of 11.36 investigated here and is studied
using DLS and fluorescence spectrocopy.
PACS numbers: 82.70.Dd, 61.20.Lc, 83.50.Ax, 83.80.Hj
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1. INTRODUCTION
In recent times, block copolymers have emerged as a potential agent for targeted drug
delivery and gene therapy [1–5]. One such block copolymer proposed for controlled drug
delivery is Pluronic, which has a triblock PEO-PPO-PEO structure (PEO: polyethylene
oxide, PPO: polypropylene oxide). At high temperatures, the central PPO block becomes
hydrophobic, while the PEO blocks remain hydrophilic [6]. Due to this amphiphilic na-
ture, Pluronic molecules, above a critical temperature and concentration, self-aggregate in
aqueous solutions to form spherical micelles with hydrophobic PPO cores surrounded by
hydrophilic PEO coronas. As the copolymer concentration is increased, the micelles can
arrange themselves in cubic crystalline order [7, 8]. This results in a transition from a liquid
to a soft solid phase [9]. The micellization process and the phase behavior of pure Pluronic
solutions are found to depend upon solution temperature, copolymer concentration and
molecular architecture and have been studied using differential scanning calorimetry (DSC),
static and dynamic light scattering (SLS and DLS, respectively), small angle neutron scat-
tering (SANS) and surface tension measurements [10–13].
The sizes of Pluronic micelles and the phase behavior of Pluronic solutions show dramatic
changes in the presence of certain additives. The addition of the anionic surfactant sodium
dodecyl sulphate (SDS) to micellar Pluronic solutions, for example, leads to the formation of
mixed micelles. These solutions have been studied using DSC, isothermal titration calorime-
try (ITC), SLS and DLS, electromotive force (emf) and surafce tension measurements and
rheology [14–20].
The formation of micellar block copolymer-drug complexes was first proposed by Dorn et
al. [21]. When hydrophobic drug molecules are mixed with suitable quantities of Pluronic
molecules and the temperature is raised, the drug molecules accumulate in the hydrophobic
PPO cores. The hydrated PEO coronas are non-toxic and prevent the drug molecules from
being removed from the core. The solubilities of the hydrophobic drugs therefore increase
substantially in an aqueous medium, enhancing the bioavailability of the drugs [22]. It has
been reported that the passive accumulation of drugs encapsulated in Pluronic micelles at
solid tumor cells is more efficient than that of free drugs [2]. This arises from the long circu-
lation time of the drug-encapsulated micelles and the slow dissociation of drugs from these
micelles in the blood circulation system [2]. Drug-encapsulated Pluronic micelles can also
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enhance the transport of drugs across the blood-brain and intestinal barriers [1, 2]. These
and other pharmaceutical advantages of Pluronic micelles make it a serious contender as a
drug carrier [23].
The solubilization of drugs in Pluronic micelles has been extensively studied in recent
times. It is reported in the literature that the presence of the hydrophobic drug molecules
naproxen and indomethacin in F127 solutions results in slight decreases in the micellar
sizes and aggregation numbers, in addition to a lowering of the gelation temperature [24].
The aggregation behavior of F127 micelles was studied systematicaly when drugs of varying
hydrophobicities were incorporated in the micellar cores [25]. It was found that the most
hydrophobic drugs increased the sizes of the micellar core and corona while generally decreas-
ing the micellar aggregation numbers. Scherlund et al. observed a decrease in the critical
micellization temperature (CMT) and the gelation temperature when local anesthetics were
added to Pluronic solutions [4]. These authors further confirmed that these temperatures
decreased with dilution and increase in solution pH. More recently, Foster et al. encapsu-
lated Ibuprofen molecules in Pluronic P-104 and P-105 solutions and Flurbiprofen molecules
in P103 and P123 solutions. Using SANS and pulsed-field gradient stimulated-echo nuclear
magnetic resonance (NMR) measurements, they demonstrated that the encapsulation of
drugs favors the micellization process, resulting in an increase in the aggregation number
and the micellar core radius [26, 27]. A strong dependence of the aggregation number and
the core radius on the solution pH was reported when Ibuprofen was added to P104 solutions
and Flurbiprofen to P103 and P123 solutions [28, 29].
In this work, the non-steroidal anti-inflammatory drug Ibuprofen, the salicylate analgesic
drug Aspirin and the macrolide antibiotic drug Erythromycin are encapsulated in the hy-
drophobic cores of spherical Pluronic F127 micelles. The dilute, completely fluid-like F127
solutions used here are studied at several temperatures and pH values and are prepared at
concentrations that are much higher than the critical micellization concentrations of F127
at the temperatures studied. The encapsulation of drugs in Pluronic F127 micelles is stud-
ied using cryo-SEM, DLS, small angle X-ray scattering and fluorescence spectroscopy. The
changes in the CMTs of the solutions, the variations in the hydrodynamic radii of the mi-
celles containing the encapsulated drugs and the micellar polydispersities are investigated
using DLS. The temperature dependence of the encapsulation process and the penetration of
solvent in the micellar core are studied using fluorescence spectroscopy. Finally, the release
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of the drugs from the micellar cores when solution pH is increased is reported.
2. MATERIALS AND METHODS
2.1. Sample Preparation. Pluronic F127, Ibuprofen, Aspirin and Erythromycin were
purchased from Sigma-Aldrich and used as received without further purification. Pluronic
F127 is a triblock copolymer [PEO100PPO70PEO100] and has a molecular weight of 12,600
g/mol, a critical micellization concentration of 0.725 wt% at 25◦C. Ibuprofen (mol. wt.
206.29 g/mol), Aspirin (mol. wt. 180.16 g/mol) and Erythromycin (mol. wt. 733.93
g/mol) are three aromatic hydrophobic drug molecules characterized by different chemical
architectures (Fig. 1). All these drug molecules are weakly acidic in aqueous solutions.
Aspirin is more acidic (pKa 3.5) compared to Ibuprofen (pKa 5.38) and Erythromycin (pKa
8.8) [30–32]. To prepare a pure F127 solution, an appropriate amount of F127 was dissolved
in deionized and distilled Millipore water and stirred vigorously with a magnetic stirrer. Of
the three drug molecules used in this study, Ibuprofen is the most hydrophobic, followed by
Erythromycin and Aspirin (Table 1).
F127 solutions were prepared at concentrations 5.26 wt%, 2.04 wt% and 1.02 wt%.
These concentrations are much higher than the CMCs of the F127 solutions at the
temperatures studied in this work. Drug molecules were incorporated in Pluronic F127
micelles by vigorously stirring aqueous mixtures of the drugs and F127 in an ultrasonicator
at temperatures between 40◦C and 60◦C.
2.2. DLS Measurements. A BIC (Brookhaven Instruments Corporation) BI-200SM
spectrometer was used to measure the scattered light intensity at scattering angles between
60◦ and 135◦. A 150 mW solid state laser (NdYVO4, Spectra Physics Excelsior) with
wavelength 532 nm was used as the light source. The sample cell was held in a brass
thermostat block filled with decalin, a refractive index matching liquid. The temperature
of the sample cell was controlled between 10◦C and 80◦C with the help of a temperature
controller (Polyscience Digital). A Brookhaven BI-9000AT Digital Autocorrelator was used
to measure the intensity auto-correlation functions of the light scattered from the samples.
The intensity auto-correlation function G(2)(τ) is defined as G(2)(τ) = <I(0)I(τ)>
<I(0)>2
= 1 +
A|g(1)(τ)|2 [33], where I(τ) is the intensity at time τ , g(1)(τ) is the normalized electric field
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auto-correlation function, A is the coherence factor, and the angular brackets <> represent
an average over time. If the sample is monodisperse and dilute, g(1)(τ) ∼ exp(−τ/τR), where
τR is the relaxation time. For spherical colloidal particles diffusing in a solvent of refractive
index n, 1/τR = Dq
2, where D is the translational diffusion coefficient and q = 4pin
λ
sin(θ/2)
is the scattering wave vector at a scattering angle θ and for a wavelength λ. The effective
hydrodynamic radius RH of the scatterer is estimated using the Stokes-Einstein relation
D = kBT/6piηRH , where kB is the Boltzmann constant, T is the temperature and η is the
viscosity of the solvent [34]. Since the samples used in this study were highly polydisperse,
the normalized correlation functions [C(τ) = G(2)(τ) −1] were fitted to stretched exponential
functions of the form C(τ) ∼ exp(−τ/τR)β. Polydispersity values were extracted using
the protocol detailed in Part B of the ‘Analysis and Calculations’ section of Supporting
Information.
2.3. Cryo-SEM (scanning electron microscopy) measurements. For the cryo-
SEM experiments, the samples were cryo-fractured by quickly dipping them into liquid
nitrogen. The frozen samples were then transferred to a PP3000T cryo unit (Quorum
Technologies) and cut with a cold knife. The fractured and cut samples were sublimated
at −130◦C for 5 minutes and then sputtered with platinum for ninety seconds inside the
unit. The samples were imaged using a Zeiss Ultra Plus cryo-SEM setup at a temperature
of −160◦C.
2.4. Fluorescence measurements. For each fluorescence measurement, 5 × 10−7M
pyrene was added to the Pluronic micellar solutions. The samples were stirred in an ul-
trasonicator for sufficient time to encapsulate the pyrene molecules in the micellar cores.
The samples were then kept in quartz cells and excited with light of wavelength 339 nm
in a Horiba Jobin Yvon FluoroMax-4 Spectrofluorometer. Changes in the emission spectra
due to drug incorporation and changes in temperature and pH were detected using a R928P
photomultiplier tube. This method is widely used to study micellization phenomena [35–40].
2.5. Small angle X-ray scattering (SAXS). Small angle X-ray scattering (SAXS)
was performed using a Hecus S3-Micro System using a Cu Kα(λ = 1.54A˚). The scattered
intensity was measured with a one-dimensional position sensitive detector (PSD). The X-ray
diffraction studies were carried out on samples loaded in 1.0 mm diameter glass capillaries.
2.6. pH measurement. pH measurements were done using an Eutech pH-meter. The
pH-meter was calibrated by using three buffer solutions of pH 4.01, 7.00 and 10.01.
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3. RESULTS AND DISCUSSION
Direct visualization of the Pluronic F127 micelles was performed with cryo-SEM. The
samples, initially at room temperature (25◦C), were cryo-fractured in liquid nitrogen. A
representative image of a 5.26 wt% F127 solution is shown in Fig. 2(a). The globular
structures of F127 micelles, of average sizes 68-70 nm, are clearly visible. When drug
molecules are added Pluronic micellar solutions, they assemble in the hydrophobic core.
The cryo-SEM images of F127 micelles encapsulating 0.1 wt% each of Ibuprofen, Aspirin
and Erythromycin respectively are shown in Figs. 2 (b), (c) and (d), respectively. In each
sample, the micelles retain their globular structures. In the concentration range investigated,
cylindrical or lamellar aggregates [41, 42] were not observed. The size distributions of these
drug-encapsulated micelles are plotted in Fig. S1 of Supporting Information and the methods
adopted for these estimates are detailed in Part A of the ‘Analysis and Calculations’ section.
In contrast to cryo-SEM, DLS is a non-invasive technique and yields sizes and distribu-
tions over the entire scattering volume. Systematic DLS measurements were next performed
at several temperatures with 5.26 wt% F127 solutions, with and without drugs. In these
measurements, the normalized intensity auto-correlation functions C(τ) were measured at
sixl scattering angles while varying the delay times τ at several temperatures within the
range 12◦C - 60◦C. Fig. 3 shows the data at 60◦C (squares), 40◦C (down-triangles) and
25◦C (up-triangles) for 5.26 wt% F127 solutions. The fits to the stretched exponential
functional form, C(τ) ∼ exp(−τ/τR)β, are shown by solid lines. For every sample, C(τ)
is measured at six different q values and the corresponding τR and β are extracted. The
mean relaxation time < τR > is estimated using the relation < τR > = τR/β ∗ Γ(1/β)
(details of the calculation are included in Part B of the ‘Analysis and Calculations’ section
of Supporting Information). The inset of Fig. 3 shows that at all three temperatures,
1/ < τR > varies linearly with q
2 with 1/ < τR > → 0 as q → 0, a signature of the diffusive
motion of the nearly spherical micelles. If the sample temperature is lowered to 20◦C
(circles in Fig. 3), C(τ) no longer fits to a stretched exponential form. This indicates the
breakup of the spherical micelles into free unimers in solution and indirectly establishes
that the CMT of the sample lies between 20◦C and 25◦C. By systematically inspecting
the shape change of C(τ) from stretched exponential to non-exponential as temperature is
decreased, the CMT of this sample is estimated to be 23◦±1◦C. This estimate matches well
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with previous results obtained using DSC [10], SLS and fluorescence spectroscopy [43] and
is also confirmed by our cryo-SEM images which show that the F127 solution, quenched
rapidly from 25◦C, is constituted by spherical micelles (Fig. 2(a)).
DLS measurements were next performed after incorporating different quantities of drug
molecules in 5.26 wt% F127 solutions in the temperature range 12◦C - 60◦C. It was observed
that the C(τ) data in this entire temperature range fit well to stretched exponential functions
(Fig. 4). For all the data acquired, 1/ < τR > varies linearly with q
2 (inset (a) of Fig.
4), suggesting that the samples are in the micellar liquid phase. The CMTs of all the
drug-incorporated micellar samples therefore lie below the experimental temperature limit
of 12◦C. The reduction in the CMTs of the micellar solutions observed here due to drug
encapsulation is consistent with previous reports [4, 26]. The hydrophobicity of the PPO
cores increases considerably due to the addition of the drug molecules. This favours micellar
aggregation at lower temperatures, resulting in the observed lowering of the CMT.
The acceleration of the aggregation process with increasing hydrophobicity of the micellar
core is further confirmed by our observation that increasing drug hydrophobicity leads to
micelle formation at lower threshold concentrations. The shapes of the C(τ) vs. τ plots in
the temperature range 12◦C - 60◦C are studied at several drug concentrations at different
q values. For very low drug concentrations, C(τ) changes from a stretched exponential to
a non-exponential form at around 23◦C, the CMT of pure F127 solutions. When drugs are
added to the micellar solutions above a thresold concentration Ct, a rather abrupt decrease
in the solution CMT is noticed, and the auto-correlation function is always of stretched
exponential form in the experimental temperature range. In Table 1, the octanol-water
partition coefficients (log [Poct/water]) [44], which are measures of the hydrophobicity of the
three drugs used here, are listed alongside our estimates of Ct. It is seen that an increase
in the partition coefficient reduces Ct, thereby favoring the formation of micelles at lower
concentrations.
SAXS measurements were also performed to confirm the lowering of the CMT of an
Ibuprofen-encapsulated F127 solution above Ct. The data is shown in the inset (b) of Fig.
4, where the scattered X-ray intensity I(q) is plotted vs. q for 60◦C (circle-line) and 4◦C
(solid line). At 60◦ C, a peak in I(q) at q = 0.004 1/nm is seen, which indicates the presence
of micellar structures with diameters of 2pi/q = 15.7±0.1 nm in solution. At 4◦C, the
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peak completely disappears, confirming the absence of spherical micelles. Combining the
X-ray and DLS measurements, it is concluded that the CMT of the Ibuprofen-encapsulated
F127 micellar solutions lies somewhere in the range between 4◦C and 12◦C. This confirms
our earlier observation that drug encapsulation stabilizes F127 micelles over a broader
temperature range.
Aspirin and Erythromycin were also added to 5.26 wt% F127 solutions above their
respective Ct values and DLS measurements were performed. Similar to the data of Fig. 4,
the C(τ) vs. τ plots show fits to stretched exponential forms in the temperature range 12◦C
- 60◦C (representative data shown in Figs. S2(a) - S2(d) of Supporting Information). For
every experiment, the relaxation time τR is obtained at each q. It is seen that 1/ < τR >
varies linearly with q2 with 1/ < τR > → 0 as q → 0 in all cases (insets of Figs. S2(a)-
S2(d)). The same trends are repeated when drugs are incorporated in more dilute F127
solutions. Data for a 2.04 wt% F127 solution are displayed in Figs. S2(e) and S2(f) of
Supporting Information. The slopes of the linear fits to the 1/ < τR > vs. q
2 data yield the
translational diffusion coefficients D and the average hydrodynamic radii < RH > of the
micelles (Fig. S2 and Table S1 of Supporting Information).
In Fig. 5, the variations of < RH > of 5.26 wt% F127 solutions, without drugs and when
encapsulating 0.1 wt.% Ibuprofen, Aspirin and Erythromycin, respectively, are plotted vs.
temperature. For all the three drugs, < RH > decreases with increase in temperature, with
the increase becoming sharper at temperatures below 30◦C. Polydispersities also increase
substantially when the temperature is lowered and when drugs are incorporated in the
micellar cores. The inset of Fig. 5 displays the distributions of relaxation times for all
the samples at 40◦C. A broader distribution function, and therefore a larger full width at
half maximum (FWHM) value of the distribution, indicates higher polydispersity. Micellar
polydispersities of all the samples were estimated using the protocol detailed in Part B of
the ‘Analysis and Calculations’ section of Supporting Information. It is seen that Aspirin,
which is the least hydrophobic drug used, forms the largest and most polydisperse micelles
at this temperature, while Ibuprofen, the most hydrophobic drug used here, forms smaller,
more compact micelles. The same trends are repeated at 60◦C (Fig. S3 of Supporting
Information). At 25◦C, however, Erythromycin incorporation causes the formation of the
largest and most polydisperse micelles (Fig. S4 of Supporting Information). Greater drug
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hydrophobicity therefore ensures more compact packing of the drugs within the micellar
cores at temperatures ≥ 40◦C. This trend is repeated even when F127 concentration is
reduced (Figs. S5 and S6 of Supporting Information).
The morphologies of the micelles are therefore extremely sensitive to the molecular
architectures and hydrophobicities of their constituents. The average hydrodynamic radii of
the micelles < RH > at various temperatures and the polydispersity indices (PDIs) of these
micelles when they encapsulate different quantities of drug solutes are plotted in Figure S7
of Supporting Information as the main figure and inset, respectively. The incorporation of
drugs increases the radii of the micelles (Figs. 5 and Fig. S7), in agreement with previous
experiments involving the encapsulation of drug molecules in Pluronic block copolymer
micelles [24–26]. It is important to note here that the small sizes of the drug-encapsulated
micelles estimated here indicate that they may be sterilized simply by a filtration process
and that the micelles may be easily delivered to the blood stream through intravenous
injection. It is, however, not possible to extract any systematic correlations between
average micellar sizes and incorporated drug concentrations due to the very high micellar
polydispersities. The data for the lower F127 concentrations also display the same trends
(Fig. S8 of Supporting Information). The thermo-reversibility of the aggregation process
has also been verified. The < RH > data estimated from DLS experiments for increasing
and decreasing temperature cycles when 0.1 wt% Ibuprofen is incorporated in a 5.26 wt%
F127 solution is plotted in Fig. S9 of Supporting Information.
To confirm the increased hydration of the micellar core due to decrease in solution
temperature, fluorescence spectra of the samples were recorded using aromatic pyrene
molecules as the fluorescent probe. Pyrene molecules, being hydrophobic, stay encapsulated
in the PPO cores of the micelles. The samples were excited at a wavelength of 339 nm
with a bandwidth of 1 nm. The emission spectra, recorded at 40◦C and 8◦C, are shown in
Fig. 6(a) (solid line and circle-line, respectively). In both these spectra, the first peak, I1,
occurs at around 372 nm and the third peak, I3, occurs at around 383 nm.
Earlier studies have shown that the intensity ratio between the first and third emission
peaks of the pyrene spectrum (I1/I3) depends upon the dipole moment of the solvent
[39, 40, 45]. A significant enhancement in the intensity of the 0-0 vibronic band (which
results in the I1 peak) in the presence of a polar solvent has been reported. The I3 peak, in
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contrast, is solvent-insensitive. A transition from a non-polar to a polar environment there-
fore results in a significant increase of the I1/I3 ratio in the pyrene emission spectrum. In
Fig. 6(b), the ratios I1/I3 are plotted vs. temperature for different concentrations of drugs
added to F127 solutions. For every sample, the ratio increases with decrease in temperature.
This indicates an increase in the aqueous content of the micellar core region at lower temper-
atures. Increased solvent penetration into the micellar cores should result in looser packing
of molecules in the core and an increase in the values of < RH > at lower temperatures. This
has already been reported in Figs. 5 and S7. For the samples with CMTs above 12◦C (F127
micelles encapsulating 0 wt% Ibuprofen and 0.05 wt% Erythromycin, respectively), I1/I3
shows a very high value of around 1.7 at 8◦ C which indicates that the pyrene molecules are
in a fully aqueous environment [45]. The high values of I1/I3 seen in our measurements for
low drug encapsulation (Fig. 6(b)) indicate that the pyrene molecules are released into the
aqueous environment at 8◦C due to the breakup of the micelles into unimers. For the other
two samples with higher drug encapsulation, the increase in I1/I3 at lower temperature is
much less, which indicates a more limited amount of sovent penetration in the micellar cores.
The addition of the weakly acidic Ibuprofen molecules to non-ionic F127 solutions results
in a monotonic decrease in the sample pH. For example, the addition of 0.5 wt% Ibuprofen
to a 5.26 wt% F127 solution decreases the solution pH from 7 to 4.65. Small amounts
of NaOH were added to change the solution pH and systematic DLS measurements were
next performed. The normalized intensity auto-correlation functions C(τ), obtained in DLS
measurements for 5.26 wt% F127 solutions containing 0.5 wt% Ibuprofen at 40◦C for different
solution pH values, fit to stretched exponential functions (circles in Fig. 7(a) represent data
at pH = 11.36). When the temperature is decreased to 15◦C, the micelles dissociate into
free unimers and C(τ) [squares in Fig. 7(a)] does not fit to a stretched exponential form.
This is consistent with the high I1/I3 ratios obtained in fluorescence measurements on the
same sample [inset of Fig. 7(a)].
Inset of Fig. 7(b) shows that as solution pH is changed between 4.65 and 11.36,
1/ < τR >, extracted from DLS data acquired 40
◦C, shows a power law dependence on q:
1/ < τR > ≈ qα. Here, the exponent α gives information about the micellar dynamics.
Fig. 7(b) plots the values of α and 1/ < τR > vs. solution pH. At the low pH of 4.65, the
power law fit gives α ≈ 2, suggesting that the system consists of homogeneous, spherical,
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diffusive structures, consistent with the results displayed in Fig. 4. With an increase in
solution pH to 6.1, α increases to 2.57, indicating the presence of heterogeneous micellar
structures in solution. This increase in α is accompanied by a simultaneous decrease
in 1/ < τR >, which indicates the presence of bigger aggregates. When solution pH is
increased to 11.36, a decrease of α to 2.19 and an increase in 1/ < τR > are observed.
As changing pH should not affect the non-ionic F127 micelles, the observed changes are
brought about by the Ibuprofen molecules present in solution. With increase in solution pH,
the Ibuprofen molecules in the micellar core are ionized [28, 29]. The repulsive interactions
within the core lead to the formation of bigger, more anisotropic micelles at pH = 6.1. When
the pH of the system is further increased to 11.36, the Ibuprofen molecules, which are fully
ionized, are released from the micellar cores to the aqueous medium due to their enhanced
water solubility. The encapsulation of drug molecules is not favored under these conditions
and pure F127 micelles coexist in solution with free drug molecules. This results in the
observed decrease in α. It is to be noted here that the average hydrodynamic radii < RH >
of the micelles estimated in DLS measurement is 10.4 nm at T = 40◦C and pH = 11.36,
almost identical to the value extracted when no drugs are added (Figs. 5 and S7, Table
S1). Furthermore, by observing changes in the shapes of C(τ) from stretched exponential
to non-exponential as temperature is decreased, the CMT of the sample at pH = 11.36 is
estimated to be 24◦C, the value expected for pure F127 micellar solutions. This observation
is similar to the findings of Scherlund et al., who observed that if the active ingredients
(drugs) are mostly in ionized form at a certain pH, the CMT of the F127 solution is almost
the same as that for the pure sample [4]. The release of drugs at high pH was previously
also reported for Flurbiprofen-encapsulated P103 solutions [29].
4. CONCLUSION
In this work, three different drugs, Ibuprofen, Aspirin and Erythromycin, are encapsu-
lated in aqueous F127 micellar solutions. Cryo-SEM imaging shows the presence of globular
structures even after drug-encapsulation. The drug molecules, when added above a specific
threshold concentration Ct, enhance the stability of the micellar phase over a broad temper-
ature range. DLS experiments are performed on the drug-encapsulated micellar systems to
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determine changes in hydrodynamic radii and micellar polydispersities. The average hydro-
dynamic radii of the micelles calculated here are seen to increase upon drug incorporation,
with the polydispersity being inversely correlated to the drug hydrophobicity at the higher
temperatures. The hydrodynamic radii of the micelles increase with decrease in temper-
ature. This is consistent with data presented in [24, 25]. The increase in micellar sizes
observed when temperature is lowered is accompanied by an increase in the hydration of the
micellar core and is verified by pyrene fluorescence spectra measurements. Increasing the
temperature excludes the solvent from the micellar core due to enhanced core hydrophobic-
ity and results in more compact micelles. The drug-encapsulated micelles also show a strong
pH dependence. When pH increases from 4.65 to 6.1, the ionization of drug molecules leads
to the formation of larger micelles. Increasing the pH to 11.36 triggers the release of drug
molecules in the solvent. Drug-incorporated F127 micelles therfore have enormous potential
as drug carriers in the area of nanomedicine [23]. However, before these formulations are
made available commercially, several clinical and scientific issues relating to their toxicity
and stability need to be addressed.
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TABLE I: The octanol-water partition functions log [Poct/water] of the three drugs used here and
the Ct values obtained from the DLS data are tabulated below.
Name of drug log [Poct/water] Ct
Ibuprofen 3.5 0.03 wt.%
Aspirin 1.19 0.3 wt.%
Erythromycin 3.06 0.05 wt.%
FIG. 1: Chemical structures of (a) Ibuprofen, (b) Aspirin and (c) Erythromycin.
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FIG. 2: Cryo-SEM images of 5.26 wt% F127 micelles (a) with no encapsulated drugs, and when
(b) 0.1 wt% Ibuprofen, (c) 0.1 wt% Aspirin and (d) 0.1 wt% Erythromycin are incorporated in
the micellar cores.
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FIG. 3: The normalized intensity auto-correlation functions C(τ) plotted for a pure 5.26 wt%
F127 sample at 20◦C (circles), 25◦C (up-triangles), 40◦C (down-triangles) and 60◦C (squares).
The stretched exponential fits to the data at 60◦C, 40◦C and 25◦C are shown by solid lines. The
linear fits to 1/ < τR > vs. q
2, obtained at 60◦C, 40◦C and 25◦C, are shown in the inset (solid lines).
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FIG. 4: The normalized intensity auto-correlation functions C(τ) plotted for 5.26 wt% F127
solutions with 0.1 wt% Ibuprofen at 20◦C (circles), 25◦C (up-triangles), 40◦C (down-triangles)
and 60◦C (squares), respectively. The stretched exponential fits are shown by solid lines. The
inset (a) shows that 1/ < τR > varies linearly with q
2 for all the samples. (b) SAXS data showing
I(q) vs. q for a 5.26 wt% F127 solution incorporating 0.25 wt% Ibuprofen is plotted at 60◦C
(circle-line) and 4◦C (solid line).
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FIG. 5: Variation of < RH > with temperature for a 5.26 wt% F127 solution without drugs
(squares) and after the encapsulation of 0.1 wt% Ibuprofen (circles), 0.1 wt% Aspirin (up-triangles)
and 0.1 wt% Erythromycin (down-triangles). Inset shows the distributions of relaxation times for
F127 micellar solutions with no drugs (solid line), 0.1wt% Ibuprofen (circle-line), 0.1 wt% Aspirin
(square-line) and 0.1 wt% Erythromycin (triangle-line) at 40◦C.
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FIG. 6: (a) Pyrene emission spectra for 5.26 wt% F127 solutions at 40◦C (solid line) and 8◦C
(circle-line). Variations of I1/I3 with temperature when 0 wt% Ibuprofen (squares), 0.2 w%
Ibuprofen (up-triangles), 0.5wt% Aspirin (left-triangles) and 0.05 wt% Erythromycin (stars) are
incorporated in F127 solutions are plotted in (b).
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FIG. 7: (a) The normalized intensity auto-correlation functions C(τ) at θ = 90◦ for 5.26 wt% F127
solutions containing 0.5 wt% Ibuprofen at 40◦C (circles) and 15◦C (squares) respectively, when the
solution pH is adjusted to 11.36, are shown. I1/I3 vs. temperature is plotted in the inset of (a).
The values of α (squares) and 1/ < τR > (circles) at 40
◦C are plotted vs. solution pH in (b). Inset
of (b) shows the plots of 1/ < τR > vs. q and the corresponding fits (solid lines) to 1/τR ≈ qα at
40◦C for different pH values: 4.5 (squares), 6.1 (circles), 11.36 (triangles).
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